About one-third of patients with a slow-growing type of thyroid tumor, called papillary thyroid cancer, are eligible to delay treatment, says Dr. R. Michael Tuttle, an endocrinologist at New York's Memorial Sloan Kettering Cancer Center and lead author ...and more »
Future of Cancer Treatment: 'We're in the Midst of a Revolution in Cancer Care'
When it comes to cancer treatment, one size does not fit all. KRCU's To Your Health host Brooke Hildebrand Clubbs recently sat down with Dr. Ryan Fields, Associate Professor of Surgical Oncology at Washington University School of Medicine and the ...
No comments:
Post a Comment